New roles for the major human 3'-5' exonuclease TREX1 in human disease

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Aicardi-Goutières syndrome (AGS), Systemic Lupus Erythematosus (SLE), Familial Chilblain Lupus (FCL), and Retinal Vasculopathy and Cerebral Leukodystrophy (RVCL) were considered distinct diseases.
• RVCL is a new term encompassing Cerebroretinal Vasculopathy (CRV), Hereditary Vascular Retinopathy (HVR), and Hereditary Endotheliopathy, Retinopathy and Nephropathy (HERNS).

Purpose of the Study:

• To review the functions of the TREX1 gene.
• To explore the relationship between TREX1 mutations and the clinical, genetic, and functional aspects of AGS, SLE, FCL, and RVCL.

Main Methods:

• Genetic analysis of patients with AGS, SLE, FCL, and RVCL.
• Review of existing literature on TREX1 gene function and associated diseases.

Main Results:

• Genetic analysis demonstrated that AGS, SLE, FCL, and RVCL map to chromosome 3p21.
• Mutations in the TREX1 gene, encoding a 3'-5' exonuclease, were identified as a common cause for these conditions.

Conclusions:

• TREX1 mutations provide a unifying genetic explanation for distinct neurological and autoimmune disorders.
• Understanding TREX1 function is crucial for elucidating the pathophysiology of these related conditions.